Literature DB >> 12447357

Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics.

Joanne T Brindle1, Henrik Antti, Elaine Holmes, George Tranter, Jeremy K Nicholson, Hugh W L Bethell, Sarah Clarke, Peter M Schofield, Elaine McKilligin, David E Mosedale, David J Grainger.   

Abstract

Although a wide range of risk factors for coronary heart disease have been identified from population studies, these measures, singly or in combination, are insufficiently powerful to provide a reliable, noninvasive diagnosis of the presence of coronary heart disease. Here we show that pattern-recognition techniques applied to proton nuclear magnetic resonance (1H-NMR) spectra of human serum can correctly diagnose not only the presence, but also the severity, of coronary heart disease. Application of supervised partial least squares-discriminant analysis to orthogonal signal-corrected data sets allows >90% of subjects with stenosis of all three major coronary vessels to be distinguished from subjects with angiographically normal coronary arteries, with a specificity of >90%. Our studies show for the first time a technique capable of providing an accurate, noninvasive and rapid diagnosis of coronary heart disease that can be used clinically, either in population screening or to allow effective targeting of treatments such as statins.

Entities:  

Mesh:

Year:  2002        PMID: 12447357     DOI: 10.1038/nm1202-802

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  212 in total

Review 1.  Use of metabolomic profiling in the study of arachidonic acid metabolism in cardiovascular disease.

Authors:  Ning Li; Jun-Yan Liu; Hong Qiu; Todd R Harris; Padmini Sirish; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Congest Heart Fail       Date:  2011-01-27

Review 2.  Metabolic profiles to define the genome: can we hear the phenotypes?

Authors:  Julian L Griffin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

Review 3.  Metabolomics as a tool for cardiac research.

Authors:  Julian L Griffin; Helen Atherton; John Shockcor; Luigi Atzori
Journal:  Nat Rev Cardiol       Date:  2011-09-20       Impact factor: 32.419

Review 4.  Proteomic and metabolomic profiles in atherothrombotic vascular disease.

Authors:  Roxana Martinez-Pinna; Coral Barbas; Luis Miguel Blanco-Colio; Jose Tunon; Priscila Ramos-Mozo; Juan Antonio Lopez; Olivier Meilhac; Jean-Baptiste Michel; Jesus Egido; José Luis Martin-Ventura
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

Review 5.  A network perspective on metabolism and aging.

Authors:  Quinlyn A Soltow; Dean P Jones; Daniel E L Promislow
Journal:  Integr Comp Biol       Date:  2010-07-12       Impact factor: 3.326

Review 6.  Metabolomics in the diagnosis of acute myocardial ischemia.

Authors:  Vicente Bodi; Vannina G Marrachelli; Oliver Husser; Francisco J Chorro; Juan R Viña; Daniel Monleon
Journal:  J Cardiovasc Transl Res       Date:  2013-08-29       Impact factor: 4.132

Review 7.  The utility of metabolomics in natural product and biomarker characterization.

Authors:  Daniel G Cox; Joonseok Oh; Adam Keasling; Kim L Colson; Mark T Hamann
Journal:  Biochim Biophys Acta       Date:  2014-08-20

Review 8.  The application of NMR-based metabonomics in neurological disorders.

Authors:  Elaine Holmes; Tsz M Tsang; Sarah J Tabrizi
Journal:  NeuroRx       Date:  2006-07

9.  Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum.

Authors:  Ville-Petteri Mäkinen; Pasi Soininen; Carol Forsblom; Maija Parkkonen; Petri Ingman; Kimmo Kaski; Per-Henrik Groop; Mika Ala-Korpela
Journal:  MAGMA       Date:  2006-12-15       Impact factor: 2.310

10.  Silent myocardial ischemia is associated with altered plasma phospholipids.

Authors:  Hailong Lin; Jing Zhang; Peng Gao
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.